NCT06381154 2026-01-30
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
Mayo Clinic
Phase 2 Recruiting
Mayo Clinic
Peking University People's Hospital
University of California, San Francisco
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Ohio State University Comprehensive Cancer Center
University Hospital Southampton NHS Foundation Trust
Region Stockholm